Inventor · disambiguated record
Bing Yu
Also filed as: YU BING
15 granted patents·13 pending applications·33 citations·filing 2007–2023
89Inventor score
Files withNOVARTIS AG13HAIHE BIOPHARMA CO LTD3UNIV KENT STATE OHIO3BURKS HEATHER ELIZABETH2RADETICH BRANKO2
Top patents by PatentIndex Score
28 records- 0192US10934285B2Compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2017·Granted Mar 2, 2021·5 cites·5 claims
- 0291US10058534B2Benzothiophene derivatives and compositions thereof as selective estrogen receptor degradersNOVARTIS AG·Filed 2018·Granted Aug 28, 2018·4 cites·1 claims
- 0386US10287266B2Compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2016·Granted May 14, 2019·8 cites·13 claims
- 0486US9931317B2Benzothiophene derivatives and compositions thereof as selective estrogen receptor degradersNOVARTIS AG·Filed 2017·Granted Apr 3, 2018·2 cites·1 claims
- 0584US8877801B2Compounds and compositions as selective estrogen receptor degradersBURKS HEATHER ELIZABETH·Filed 2014·Granted Nov 4, 2014·4 cites·18 claims
- 0679US8987257B2Heterocyclic derivativesRADETICH BRANKO·Filed 2012·Granted Mar 24, 2015·7 cites·13 claims
- 0779US2024199609A1Compounds and compositions for inhibiting the activity of shp2NOVARTIS AG·Filed 2023·Application pending·0 cites
- 0871US9458163B2Heterocyclic derivativesRADETICH BRANKO·Filed 2015·Granted Oct 4, 2016·2 cites·11 claims
- 0970US11905283B2Compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2020·Granted Feb 20, 2024·0 cites·8 claims
- 1067US9321746B2Benzothiophene derivatives and compositions thereof as selective estrogen receptor degradersNOVARTIS AG·Filed 2014·Granted Apr 26, 2016·0 cites·14 claims
- 1166US10308660B2Compounds and compositions for inhibiting the activity of SHP2CHEN ZHUOLIANG·Filed 2016·Granted Jun 4, 2019·1 cites·20 claims
- 1260US2025387504A1Antibody-drug conjugates of antineoplastic compounds and methods of use thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1358US9561211B2Benzothiophene derivatives and compositions thereof as selective estrogen receptor degradersBURKS HEATHER ELIZABETH·Filed 2016·Granted Feb 7, 2017·0 cites·3 claims
- 1458US2025339547A1Met bcl-xl inhibitor antibody-drug conjugates and methods of use thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1557US12433853B2Rationally designed lawsone derivatives as antimicrobials against multidrug-resistant Staphylococcus aureusUNIV KENT STATE OHIO·Filed 2020·Granted Oct 7, 2025·0 cites·8 claims
- 1657US2023092679A1Mcl-1 inhibitor antibody-drug conjugates and methods of useNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1757US2023081720A1Mcl-1 inhibitor antibody-drug conjugates and methods of useNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1854US2025099494A1Phosphonic acid compound and prodrug thereof, and preparation methods for and uses of phosphonic acid compound and prodrug thereofHAIHE BIOPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 1953US2024269304A1Bcl-xl inhibitor antibody-drug conjugates and methods of use thereofNOVARTIS AG·Filed 2021·Application pending·0 cites
- 2051US2022409576A1Nano-particulate compositions for stimulating host innate immune responses for therapeutic applicationsUNIV KENT STATE OHIO·Filed 2020·Application pending·0 cites
- 2150US11554158B2GPNMB compositions for treatment of skin woundsNORTHEAST OHIO MEDICAL UNIV·Filed 2017·Granted Jan 17, 2023·0 cites·15 claims
- 2250US2023091510A1Antibody drug conjugates having linkers comprising hydrophilic groupsNOVARTIS AG·Filed 2020·Application pending·0 cites
- 2350US2025042857A1SOS1 Inhibitor With Pyrido-Fused Six-Membered Ring StructureHAIHE BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 2450US2024383893A1Hydroxamic Acid Compound Having ENPP1 Inhibitory Activity and Use ThereofHAIHE BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 2549US2024042051A1Mcl-1 inhibitor antibody-drug conjugates and methods of useROCCHETTI FRANCESCA·Filed 2021·Application pending·0 cites
- 2645US9216169B2Pharmaceutical composition comprising candesartan or ester thereof and chlortalidone, and use thereofTIANJIN INST PHARM RESEARCH·Filed 2012·Granted Dec 22, 2015·0 cites·5 claims
- 2745US8367821B2Preparation of eslicarbazepine and related compounds by asymmetric hydrogenationBIAL PORTELA & CA SA·Filed 2007·Granted Feb 5, 2013·0 cites·34 claims
- 2845US2020016086A1Nanoparticulate Materials and Methods for Targeting Iron Acquisition and Metabolism for Treating Bacterial InfectionsUNIV KENT STATE OHIO·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bing Yu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →